Illustrative image – not actual.
Nestle India has inked an agreement with Dr. Reddy’s Laboratories to form a joint venture (JV) company in the nutraceuticals space. The JV agreement will allow the FMCG company to bring its 'science-backed nutritional solutions' to more consumers in the country, by leveraging Dr Reddy’s retail and distribution network. The health solutions constitute vitamin, minerals, herbals and supplements of Nestlé Health Science (NHSc).
The JV company is expected to become operational in Q2 of FY25. Dr Reddy’s will hold 51 percent stake and Nestle India will own 49 percent stake.
Meanwhile, by 2024-end, the company will start the sale of coffee brand, Nespresso products, (machines and capsules) through its distribution network, online channels, and boutiques. The first Nespresso boutique is expected to be opened in Delhi, before expansion in other key cities.
Nestle India’s total sales and domestic sales grew by 9.3 percent and 8.9 percent, respectively, in the March quarter. The country proved to be the largest market worldwide for Maggi, in FY24, while confectionery portfolio delivered 'strong performance', emerging as the second-largest market for Kitkat globally.
Nestle India will have a 'call option' to increase shareholding up to 60 percent after six years, though Dr Reddy’s will continue to hold at least 40 percent stake.
